Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 800 N Glebe Rd Ste 500 ARLINGTON VA 22203-2151 |
Tel: | N/A |
Website: | https://www.evolenthealth.com |
IR: | See website |
Key People | ||
Dan Mccarthy President | Seth Blackley Chief Executive Officer, Co-Founder, Director | John Paul Johnson Chief Financial Officer |
Emily Rafferty Chief Operating Officer | Aammaad Shams Chief Accounting Officer | Jonathan D. Weinberg General Counsel |
Business Overview |
Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner. |
Financial Overview |
For the fiscal year ended 31 December 2023, Evolent Health Inc revenues increased 45% to $1.96B. Net loss applicable to common stockholders excluding extraordinary items increased from $18.7M to $142.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Total Amort of Intangibles-excl Goodwill increase from $35.2M to $91M (expense), Other Non Rec. |
Employees: | 4,700 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $3,960M as of Dec 31, 2023 |
Annual revenue (TTM): | $1,964M as of Dec 31, 2023 |
EBITDA (TTM): | $136.38M as of Dec 31, 2023 |
Net annual income (TTM): | -$142.26M as of Dec 31, 2023 |
Free cash flow (TTM): | $113.84M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $404.22M as of Dec 31, 2023 |
Shares outstanding: | 115,430,107 as of Feb 15, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |